Search
Trending Topics
Index

S&P 500

 Index

Nasdaq

 Index

Dow Jones

 Tool

ETFs

 Commodities

Oil prices

 Crypto

Bitcoin

Stocks

View all

ETFs

View all

Cryptocurrencies

View all

Tools

YMTX

Yumanity Therapeutics Inc.

Asset unavailable for trading

Yumanity Therapeutics Inc. is no longer available for trading on the stock exchange. The data shown on this page is historical and is no longer updated.

This asset is no longer available for investment.
View all assets

Price

$-

return (12m)

- Logo

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%
Price

YMTX price

Select period
Select period
Yumanity Therapeutics
If you had invested
If you had invested
exposure
years ago
7 days
30 days
6 months
YTD
1 year
5 years
10 years
15 years
ago, you would now have *
ago, you would now have:
*
*The amount considers the reinvestment of dividends.

Return on Investment YMTX

1 month
3 months
1 year
2 years
5 years
10 years
return
1 month
0.00%
3 months
0.00%
1 year
0.00%
2 years
0.00%
5 years
0.00%
10 years
0.00%
Fundamental indicators

Fundamentals YMTX

Check the fundamentals of Yumanity Therapeutics shares.

Valuation

P/E
0.00
Sector -3.14
Industry -3.14
P/BV
0.00
Sector 1.75
Industry 1.75
P/Revenue (PSR)
-
Sector 1.94
Industry 1.94
EV/EBITDA
-
Sector -204.21
Industry -204.21
EV/EBIT
-
Sector -41.36
Industry -41.36
P/EBITDA
-
Sector -19.62
Industry -19.62
P/EBIT
-
Sector -65.94
Industry -65.94
P/Total Assets
-
Sector 1.04
Industry 1.04
P/Net Current Assets
-
Sector -9.57
Industry -9.57
P/Working Capital
-
Sector -123.00
Industry -123.00
EPS
-2.95
Sector -1.81
Industry -1.81
BVPS
0.50
Sector 1.95
Industry 1.95

Efficiency

Gross Margin
0.00%
Sector 40.72%
Industry 40.72%
EBITDA Margin
-239.66%
Sector -21,198.78%
Industry -21,198.78%
EBIT Margin
-100.00%
Sector -35.70%
Industry -35.70%
Net Profit Margins
-100.00%
Sector -36.09%
Industry -36.09%
Asset Turnover
0.15
Sector 0.03
Industry 0.03

Profitability

ROE
-168.67%
Sector -59.44%
Industry -59.44%
ROA
-80.60%
Sector -60.14%
Industry -60.14%
ROIC
-
Sector -1,846.72%
Industry -1,846.72%

Dividends

Dividend yield
0.00%
Sector -
Industry -
Payout
-
Sector -
Industry -

Debt

Current Ratio
-
Sector 2.91
Industry 2.91
Net Debt / EBITDA
-
Sector -20.38
Industry -20.38
Net Debt / EBIT
-
Sector -4.13
Industry -4.13
Net Debt / Equity
-
Sector -33,112.98
Industry -33,112.98
Gross Debt / Equity
-
Sector -0.64
Industry -0.64
Equity/Assets
0.57
Sector 0.45
Industry 0.45
Liabilities/Assets
0.43
Sector 0.41
Industry 0.41

Growth

5Y Revenue CAGR
-23.90%
Sector -
Industry -
5Y Earnings CAGR
-4.13%
Sector -
Industry -
Fundamental indicators history

Fundamentals YMTX

Buy And Hold Investor Checklist

Yumanity Therapeutics Buy And Hold Investor Checklist


This checklist is for informational purposes only and does not constitute investment advice or a recommendation. The score is based on current market parameters and does not guarantee future performance. [Learn how the scoring system works.]
Price

COMPARING YMTX WITH OTHER STOCKS

Price

Stock vs Indice Comparison Tool

If you had invested
If you had invested
years ago
2 years
5 years
10 years
ago, you would now have *
ago, you would now have:
*
*This calculation reflects price variation only.

YMTX - Historical Dividends

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT

Logo Yumanity Therapeutics

Yumanity Therapeutics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

United States

6 years

Founded: 2020

2020

Time since IPO - 6 years

46

Employees

Market cap

$-

$-

Net worth

$5.48 million

$5,476,000.00

Assets

$9.58 million

$9,579,000.00

Total Shares Outstanding

10.86 million

10,855,000

Average Daily Trading Volume

$143.36 Thousand

$143,361.72

Sector

Health Care

Industry

Biotechnology

Shares

YMTX
receitas e lucros

YMTX revenue and profits

Financials

Financial Results YMTX

DRAG THE FRAME TO SEE MORE DATA
Financials

YMTX cash flow

DRAG THE FRAME TO SEE MORE DATA
Ativos e Passivos

Asset, Revenue and Profit Growth - YMTX

Pontos Relevantes

YMTX balance sheet

DRAG THE FRAME TO SEE MORE DATA
Discover more assets
Logo Biofrontera

BFRA - Biofrontera

$- -0,00% (12M)
P/E

0.00

DY

0.00%

ROE

-893.55%

P/BV

0.00
Logo McKesson

MCK - McKesson

$1,005.04 24,36% (12M)
P/E

25.96

DY

0.34%

ROE

-168.45%

P/BV

-30.85
Logo Cardinal Health

CAH - Cardinal Health

$253.37 34,07% (12M)
P/E

34.74

DY

0.81%

ROE

-63.98%

P/BV

-21.86
Logo AbbVie

ABBV - AbbVie

$294.89 39,56% (12M)
P/E

53.66

DY

2.31%

ROE

-%

P/BV

0.00
Logo Merck & Co.

MRK - Merck & Co.

$149.46 78,93% (12M)
P/E

116.34

DY

2.27%

ROE

6.97%

P/BV

8.79
Logo AstraZeneca

AZN - AstraZeneca

$186.65 16,17% (12M)
P/E

22.38

DY

1.73%

ROE

27.27%

P/BV

5.77
Logo Pfizer

PFE - Pfizer

$30.52 34,46% (12M)
P/E

39.46

DY

5.73%

ROE

4.97%

P/BV

2.00
Logo Bristol-Myers Squibb

BMY - Bristol-Myers Squibb

$62.67 42,48% (12M)
P/E

13.78

DY

5.06%

ROE

44.06%

P/BV

5.44
Logo Biofrontera

BFRA - Biofrontera

$- -0,00% (12 M)
P/L

0.00

DY

0.00%

ROE

-893.55%

P/VP

0.00
Logo McKesson

MCK - McKesson

$1,005.04 24,36% (12 M)
P/L

25.96

DY

0.34%

ROE

-168.45%

P/VP

-30.85
Logo Cardinal Health

CAH - Cardinal Health

$253.37 34,07% (12 M)
P/L

34.74

DY

0.81%

ROE

-63.98%

P/VP

-21.86
Logo AbbVie

ABBV - AbbVie

$294.89 39,56% (12 M)
P/L

53.66

DY

2.31%

ROE

-%

P/VP

0.00
Logo Merck & Co.

MRK - Merck & Co.

$149.46 78,93% (12 M)
P/L

116.34

DY

2.27%

ROE

6.97%

P/VP

8.79
Logo AstraZeneca

AZN - AstraZeneca

$186.65 16,17% (12 M)
P/L

22.38

DY

1.73%

ROE

27.27%

P/VP

5.77
Logo Pfizer

PFE - Pfizer

$30.52 34,46% (12 M)
P/L

39.46

DY

5.73%

ROE

4.97%

P/VP

2.00
Logo Bristol-Myers Squibb

BMY - Bristol-Myers Squibb

$62.67 42,48% (12 M)
P/L

13.78

DY

5.06%

ROE

44.06%

P/VP

5.44

Frequently Asked Questions

What is the price of Yumanity Therapeutics (YMTX) today?

The current price of Yumanity Therapeutics (YMTX) is $0.00. The stock began the year trading around $0.00 and is currently priced at $0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Yumanity Therapeutics (YMTX) pay dividends?

Yumanity Therapeutics (YMTX) did not pay dividends over the past year.

Is Yumanity Therapeutics (YMTX) a good investment?

Yumanity Therapeutics (YMTX) is currently trading at $0.00 with a P/E ratio of 0.00. This represents a 0% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Yumanity Therapeutics (YMTX) stock?

You can buy Yumanity Therapeutics (YMTX) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol YMTX and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Yumanity Therapeutics (YMTX) yield today?

Over the past month, Yumanity Therapeutics (YMTX) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Yumanity Therapeutics (YMTX) today at the current price of $0.00 your total investment would be $0.00.

Based on historical performance, the investment would have grown to approximately:

  • $0.00 after 1 year
  • $0.00 after 5 years
  • $0.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.